Newbridge Financial Services Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.66K | Buy |
+103
| New | +$5.66K | ﹤0.01% | 1006 |
|
|
2023
Q4 | – | Sell |
-38
| Closed | -$3.36K | – | 1180 |
|
|
2023
Q3 | $3.36K | Hold |
38
| – | – | ﹤0.01% | 1012 |
|
|
2023
Q2 | $3.29K | Hold |
38
| – | – | ﹤0.01% | 1075 |
|
|
2023
Q1 | $3.7K | Hold |
38
| – | – | ﹤0.01% | 1117 |
|
|
2022
Q4 | $3.93K | Hold |
38
| – | – | ﹤0.01% | 1106 |
|
|
2022
Q3 | $3K | Hold |
38
| – | – | ﹤0.01% | 1113 |
|
|
2022
Q2 | $3K | Sell |
38
-16
| -30% | -$1.26K | ﹤0.01% | 1090 |
|
|
2022
Q1 | $4K | Hold |
54
| – | – | ﹤0.01% | 1128 |
|
|
2021
Q4 | $5K | Sell |
54
-484
| -90% | -$44.8K | ﹤0.01% | 1059 |
|
|
2021
Q3 | $42K | Hold |
538
| – | – | 0.03% | 461 |
|
|
2021
Q2 | $45K | Buy |
538
+500
| +1,316% | +$41.8K | 0.03% | 473 |
|
|
2021
Q1 | $3K | Buy |
+38
| New | +$3K | ﹤0.01% | 1106 |
|